Transgene Future Growth
Future criteria checks 2/6
Transgene is forecast to grow earnings and revenue by 29.2% and 70.4% per annum respectively while EPS is expected to decline by 1.8% per annum.
Key information
29.2%
Earnings growth rate
-1.8%
EPS growth rate
Biotechs earnings growth | 21.1% |
Revenue growth rate | 70.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 07 Jul 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 50 | -21 | -20 | N/A | 1 |
12/31/2024 | 40 | -14 | -13 | N/A | 1 |
12/31/2023 | 7 | -42 | -13 | N/A | 1 |
6/30/2023 | 9 | -33 | N/A | N/A | N/A |
3/31/2023 | 10 | -33 | N/A | N/A | N/A |
12/31/2022 | 10 | -33 | -22 | -20 | N/A |
9/30/2022 | 14 | -28 | -22 | -21 | N/A |
6/30/2022 | 18 | -23 | -28 | -27 | N/A |
3/31/2022 | 18 | -21 | -30 | -30 | N/A |
12/31/2021 | 17 | -20 | -27 | -26 | N/A |
9/30/2021 | 13 | -23 | -29 | -28 | N/A |
6/30/2021 | 9 | -27 | -31 | -30 | N/A |
3/31/2021 | 9 | -22 | -30 | -29 | N/A |
12/31/2020 | 10 | -17 | -30 | -29 | N/A |
9/30/2020 | 12 | -11 | -31 | -30 | N/A |
6/30/2020 | 14 | -6 | -33 | -31 | N/A |
3/31/2020 | 14 | -12 | -28 | -27 | N/A |
12/31/2019 | 13 | -19 | -24 | -22 | N/A |
9/30/2019 | 11 | -6 | -24 | -23 | N/A |
6/30/2019 | 8 | 8 | -23 | -23 | N/A |
3/31/2019 | 8 | 8 | -26 | -25 | N/A |
12/31/2018 | 7 | 8 | -29 | -28 | N/A |
9/30/2018 | 7 | -10 | -31 | -29 | N/A |
6/30/2018 | 7 | -29 | -32 | -30 | N/A |
3/31/2018 | 7 | -31 | -34 | -33 | N/A |
12/31/2017 | 7 | -32 | -36 | -35 | N/A |
9/30/2017 | 8 | -32 | -36 | -36 | N/A |
6/30/2017 | 9 | -31 | -37 | -37 | N/A |
3/31/2017 | 9 | -28 | N/A | -35 | N/A |
12/31/2016 | 10 | -24 | N/A | -34 | N/A |
9/30/2016 | 10 | -26 | N/A | -37 | N/A |
6/30/2016 | 9 | -28 | N/A | -40 | N/A |
3/31/2016 | 9 | -33 | N/A | -43 | N/A |
12/31/2015 | 10 | -38 | N/A | -45 | N/A |
9/30/2015 | 10 | -40 | N/A | -48 | N/A |
6/30/2015 | 10 | -42 | N/A | -50 | N/A |
3/31/2015 | 11 | -41 | N/A | -52 | N/A |
12/31/2014 | 11 | -41 | N/A | -54 | N/A |
9/30/2014 | 13 | -41 | N/A | -52 | N/A |
6/30/2014 | 15 | -41 | N/A | -50 | N/A |
3/31/2014 | 15 | -42 | N/A | -50 | N/A |
12/31/2013 | 16 | -43 | N/A | -50 | N/A |
9/30/2013 | 15 | -44 | N/A | -48 | N/A |
6/30/2013 | 14 | -45 | N/A | -46 | N/A |
3/31/2013 | 13 | -44 | N/A | -48 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TRGN.F is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TRGN.F is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TRGN.F is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TRGN.F's revenue (70.4% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: TRGN.F's revenue (70.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TRGN.F's Return on Equity is forecast to be high in 3 years time